Marker Therapeutics' GAAP loss for 2021 was $41.879 million, up 45.9% from $28.706 million in the prior year. Revenue increased 2.7 times to $1.242 million from $0.466 million a year earlier.
Marker Therapeutics' GAAP loss for 2021 was $41.879 million, up 45.9% from $28.706 million in the prior year. Revenue increased 2.7 times to $1.242 million from $0.466 million a year earlier. 
ir.markertherapeutics.com
English (US) 